InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,408.42
(
-1.73%
)
US TECH 100
17,870.94
(
-3.09%
)
Dow Jones
40,345.41
(
-1.01%
)
Brent Oil
70.89
(
-0.71%
)
Bitcoin
54,444.80
(
0.91%
)
Post# of 179951
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Drannac

Send PM Follow Ignore
Followers 7
Posts 1957
Boards Moderated 0
Alias Born 05/19/2015

Drannac

Re: None

Tuesday, 06/04/2019 11:35:32 AM

Tuesday, June 04, 2019 11:35:32 AM

Post# of 179951
Thinking about what could have persuaded Illiad Research to value POTN above .45/share during Q1... It wasn't Q1 revs and certainly not earnings, nor the possibility of SEC reporting or uplisting since both were too far into the future and high risk several months ago. My best guess is that POTN has inked a distribution deal with a national pharmacy chain like CVS - and their edible CBD products will be available as soon as the FDA clarifies their rulings.

Anybody have other ideas?
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up